Concomitant acute pulmonary embolism, intracardiac thrombus and renal artery thrombosis in COVID-19 patient [0.03%]
一起COVID-19患者的并发急性肺栓塞、心脏内血栓和肾动脉血栓事件
Meriem Boui,Nabil Hammoune,Badr Slioui et al.
Meriem Boui et al.
Case Reports
Thrombosis update. 2021 May:3:100042. DOI:10.1016/j.tru.2021.100042 2021
Don't forget arterial thrombosis in patients with COVID-19: A case series [0.03%]
勿忽视COVID-19患者的动脉血栓形成：一例报告系列
Daniel D Gold,Ramzi Kurd,Sharon Einav
Daniel D Gold
Introduction: The acute disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS COV-2) is accompanied by a hypercoagulable state. Multiple publications have described the venous thromboembolic events a...
Case Reports
Thrombosis update. 2021 Dec:5:100065. DOI:10.1016/j.tru.2021.100065 2021
Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19 [0.03%]
用于预防和治疗COVID-19血栓事件的疗法考虑因素
Faria Khimani,Adam J Wolf,Braian Yoon et al.
Faria Khimani et al.
Thrombosis is a known complication of SARS-CoV-2 infection, particularly within a severely symptomatic subset of patients with COVID-19 disease, in whom an aggressive host immune response leads to cytokine storm syndrome (CSS). The incidenc...
Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis [0.03%]
COVID-19住院患者的静脉血栓栓塞症的临床特点和转归：系统评价和 meta 分析
Joshua Henrina,Iwan Cahyo Santosa Putra,Irvan Cahyadi et al.
Joshua Henrina et al.
Venous thromboembolism is prevalent in hospitalized COVID-19 patients. Through systematic review and meta-analysis, we have investigated the differences in clinical characteristics and outcome of hospitalized COVID-19 patients with (+) and ...
Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices [0.03%]
爱尔兰的疫苗诱导血栓和血小板减少症(VITT)：病例回顾及目前诊治方法综述
D Swan,H Enright,R Desmond et al.
D Swan et al.
Since the beginning of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) virus pandemic, several highly effective and safe vaccines have been produced at remarkable speed. Following global implementation of vaccination progra...
COVID-19 as a trigger for splenic infarction in a patient with sickle cell trait: A case report [0.03%]
一起与新冠肺炎相关的轻型镰状红细胞增多症患者的脾梗死的病例报告
Álvaro Alejandre-de-Oña,Jaime Alonso-Muñoz,Pablo Demelo-Rodríguez et al.
Álvaro Alejandre-de-Oña et al.
Sickle cell trait (SCT) is the carrier state for sickle cell disease (SCD) and is usually perceived as a mild condition; however, previous studies have shown that hypoxemia may trigger sickle-cell related complications in these patients, in...
Case Reports
Thrombosis update. 2021 May:3:100047. DOI:10.1016/j.tru.2021.100047 2021
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) - Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) [0.03%]
mRNA新冠疫苗(BNT162b2)接种后发生的血栓——是时候将目光放在血小板减少性血栓综合征(TTS)之外了
Zohaib Yousaf,Fateen Ata,Riyadh Ali Mohammed Hammamy
Zohaib Yousaf
The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipa...
Case Reports
Thrombosis update. 2022 May:7:100104. DOI:10.1016/j.tru.2022.100104 2022
Surviving and thriving in thrombosis research during a global pandemic: Experiences of a vascular scientist diagnosed with COVID-19 [0.03%]
COVID-19疫情期间血栓研究的生存与发展——一位血管疾病科学家的亲身经历及感悟
Addie B Spier,Colin E Evans
Addie B Spier
The 2019-2020 COVID-19 outbreak resulted in widespread suffering along with major changes in the ways that researchers carry out their work. This article profiles the experiences of an early-career investigator in thrombosis research who wo...
The interplay between inflammation and thrombosis in COVID-19: Mechanisms, therapeutic strategies, and challenges [0.03%]
COVID-19中炎症与血栓形成的关系：机制、治疗策略及挑战
Li Ma,Joanne Willey
Li Ma
Coronavirus disease 2019 (COVID-19), caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can cause life-threatening pathology characterized by a dysregulated immune response and coagulopathy. While respiratory failure ...